Children who have their adenoids out do not get fewer upper respiratory infections

September 7, 2011

Children who have their adenoids surgically removed do not get fewer upper respiratory tract infections such as sinusitis and colds, finds research published in BMJ today.

Upper are extremely common in children and many of them are referred for ear, nose and throat (ENT) surgery. Indeed, having taken out (adenoidectomy) is one of the most frequently performed surgical procedures in children in western countries, says the study.

One of the main reasons adenoidectomy is performed is to reduce the incidence of upper respiratory tract infections. However, the of the procedure in children with recurrent upper respiratory tract infections is lacking, say the authors, led by Professor Anne Schilder from the University Medical Centre Utrecht.

Schilder and colleagues studied a group of 111 children aged between one and six selected for adenoidectomy, half of them were assigned to have the operation, the other half initially not.

The research took place between April 2007 and October 2010 across 11 general hospitals and two academic centres in the Netherlands. The participants were followed up for 24 months after surgery.

The results show that the children in the adenoidectomy group had 7.91 episodes of upper respiratory tract infections per person compared with 7.84 episodes in the other group. Days of absence from school or day care, and health related quality of life, was similar in both groups.

The findings also reveal that the prevalence of upper respiratory tract infections decreased over time for both groups.

In conclusion the authors say "in children selected for adenoidectomy for recurrent upper respiratory tract infections, a strategy of immediate surgery confers no clinical benefits over a strategy of initial watchful waiting."

In an accompanying editorial, Professor Kari Kvaerner from Oslo University Hospital concurs that the best way for health professionals to treat children with recurrent infections appears to be "careful follow-up and a strategy of watchful waiting."

Related Stories

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.